Some notes on the question of the hypotensive activity of urokinase
Caprino, L.; Borrelli, F.; Bergesi, G.; Marchetti, E.
Thrombosis and Haemostasis 42(2): 820-821
1979
ISSN/ISBN: 0340-6245 PMID: 505389 Document Number: 150391
Document emailed within 1 workday
Related Documents
Geratz, J.D.; Shaver, S.R.; Tidwell, R.R. 1981: Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation Thrombosis Research 24(1-2): 73-83Da Rocha, M.I. 1988: Population, reproduction and health: notes on the question of a social policy Revista Brasileira de Estudos de Populacao 5(2): 21-33
Samama, M.; Cazenave, B.; Otero, A.M. 1979: Urokinase i and ii activity Thrombosis and Haemostasis 40(3): 578-580
Kirchheimer, J.C.; Nong, Y.H.; Remold, H.G. 1988: IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes Journal of Immunology 141(12): 4229-4234
Ueno, T.; Kobayashi, N.; Maekawa, T. 1979: Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase Thrombosis and Haemostasis 42(3): 885-894
Collen, D.; De Cock, F.; Lijnen, H.R. 1984: Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys Thrombosis and Haemostasis 52(1): 24-26
Coppi, G.; Borella, F.; Gatti, M.T.; Comini, A.; Dall' Asta, L. 1989: New isosorbide 5-mononitrate derivative with hypotensive activity Bollettino Chimico Farmaceutico 128(2): 74-76
Manchanda, N.; Schwartz, B.S. 1990: Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity Journal of Immunology 145(12): 4174-4180
Ranise, A.; Bondavalli, F.; Mariani, E.; Schenone, P.; Lampa, E.; Giordano, L.; Vacca, C.; Marmo, E. 1983: Derivatives of 1,3,3-trimethyl-6-azabicyclo[3.2.1]octane with hypotensive activity. Ii Il Farmaco; Edizione Scientifica 38(11): 884-892
Dayi, H.; Zhimin, X. 1997: Evaluation of the patency rate of infarct-related artery after intravenous urokinase in acute myocardial infarction by 90 minutes angiography. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(3): 184-186
Akunts, K.B.; Akunts, N.S.; Sulian, A.M. 1979: Histidase and urokinase activity of the umbilical blood at birth of infants who have had a nephropathic fetopathy Voprosy Okhrany Materinstva i Detstva 24(11): 63-65
Tanaka, O.; Hayashi, S.; Hayashi, S.; Meguro, T.; Yamada, K. 1989: Fundamental examination of measurement of urinary urokinase inhibitor activity using chromogenic substrate Rinsho Byori. Japanese Journal of Clinical Pathology 37(6): 687-691
Pućkowska, A.; Midura-Nowaczek, K.; Bruzgo, I. 2008: Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase Acta Poloniae Pharmaceutica 65(2): 213-215
Mkhitarian, V.G.; Mezhlumian, L.M. 1972: Histidase and urokinase activity in the blood and liver of the rat in alloxan diabetes and the effect of insulin on their activities Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny 12(4): 18-24
Brattström, A.; Tölg, W.; Kalkoff, W. 1978: Activity of pressoreceptors of the aortic arch in rabbits during infusion of hypotensive drugs Acta Biologica et Medica Germanica 37(10): 1633-1635
de Maat, M.P.; Dooijewaard, G.; Meijer, P.; Binder, B.R.; Keber, D.; Risberg, B.; Kluft, C.; Jespersen, J. 2001: Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 453-458
Tabolin, V.A.; Smirnova, T.A.; Burobin, V.A.; Taubkin, R.L. 1977: Histidase and urokinase activity in the liver tissue and umbilical blood serum of premature newborn infants Voprosy Okhrany Materinstva i Detstva 22(4): 61-64
Theiss, W.; Asbeck, F.; Kriessmann, A.; Trübestein, G.; Knoch, K.; de Swart, C.A.; Marbert, G.A.; van de Loo, J.C. 1983: Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase Thrombosis and Haemostasis 50(3): 664-668
Nerlov, C.; Rørth, P.; Blasi, F.; Johnsen, M. 1991: Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity Oncogene 6(9): 1583-1592
Bondavalli, F.; Bruno, O.; Mariani, E.; Schenone, P.; Berrino, L.; Filippelli, W.; Tortora, G.; Marmo, E. 1987: Esters of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)-1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypotensive activity Il Farmaco; Edizione Scientifica 42(3): 175-183